Pitt innovators were issued six U.S. patents in March 2024.
Featured Patent: 11,931,423: “Glucose Oxidase-Nanoparticle Bioconjugates for Cancer Treatment and Uses Thereof”
Use of radiotherapy to treat cancer often results in healthy tissue damage. Pitt innovators have developed a series of bioconjugates for a novel reactive oxygen species-induced cancer therapy that have minimum side effects, long term effectiveness and are highly tumor specific.The bioconjugates have demonstrated highly specific tumor uptake, which can be attributed to specificity of the targeting probes attached on their surface and enhanced permeability and retention induced by their size.
For more information on this technology, including licensing, contact us at partner@pitt.edu.
Below is a listing of all patents issued to Pitt innovators in March 2024. You can also search all Pitt technologies available for licensing.
| Patent Number |
Title | Inventor(s) | Licensing Manager | Status | |||
| 11,931,423 | Glucose Oxidase-Nanoparticle Bioconjugates for Cancer Treatment and Uses Thereof | Di Gao; Jiamin Wu; Dexing Jeng | Janice Panza | Available for Licensing | |||
| 11,918,727 | Extracorporeal Ambulatory Assist Lung | James Antaki; Gregory Burgreen; William Federspiel; Brian Frankowski; Shalv Madhani | Maria Vanegas | Licensed | |||
| 11,925,802 | Peripheral Neuromodulation to Treat Bladder and Bowel Dysfunction | Changfeng Tai | Maria Vanegas | Available for Licensing | |||
| 11,918,793 | Methods and Devices for Use in Treatment of Plantar Fasciitis and Fat Grafting | Jeffrey Gusenoff; Beth Gusenoff | Janice Panza | Licensed | |||
| 11,938,248 | Electrospinning With Sacrificial Template for Paterning Fibrous Constructs | James Clampffer III; Eric Jeffries ; Yadong Wang | Janice Panza | Available for Licensing | |||
| 11,925,611 | Use of ZT-1A and Analogs to Prevent and/or Treat Neurodegenerative or Neurocognitive Disorders | Mohammad Bhuiyan; Dandan Sun; | Maria Vanegas | Available for Licensing |